Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Co.'s product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. We show 36 historical shares outstanding datapoints in our SNOA shares outstanding history coverage, used to compute SNOA market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SNOA market cap history over the course of time is important for investors
interested in comparing SNOA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SNOA versus a peer is one thing; comparing
SNOA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SNOA can fluctuate over the course of history.
With this page we aim to empower investors researching SNOA by allowing them to research the SNOA market cap history. |
Free SNOA Email Alerts:
Video: The Importance of Market Cap
